Merlin Capital’s CRISPR Therapeutics CRSP Stock Holding History

Merlin Capital’s Portfolio CRSP Stock Details CRSP Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$605K	Sell
2023 Q4	$559K	Sell
2023 Q3	$413K	Buy
2023 Q2	$494K	Buy
2023 Q1	$330K	Buy
2022 Q4	$277K	Buy
2022 Q3	$396K	Buy